These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8144721)

  • 1. Another cause of gynecomastia.
    Dove F
    Hosp Pract (Off Ed); 1994 Apr; 29(4):27. PubMed ID: 8144721
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gynecomastia in spironolactone therapy].
    Vetter H
    Dtsch Med Wochenschr; 1979 May; 104(21):762. PubMed ID: 446292
    [No Abstract]   [Full Text] [Related]  

  • 3. Spironolactone-induced gynecomastia.
    Cuculi F; Suter A; Erne P
    CMAJ; 2007 Feb; 176(5):620. PubMed ID: 17325324
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced gynecomastia].
    Schirren U; Hinz B; Schirren C
    Andrologia; 1986; 18(1):104-7. PubMed ID: 3954080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sprironolactone-induced gynecomastia].
    Keil-Kuri E; Marshall M
    Z Allgemeinmed; 1972 Jul; 48(19):896-7. PubMed ID: 4640137
    [No Abstract]   [Full Text] [Related]  

  • 6. Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure.
    Teive HA; Munhoz RP; Werneck LC
    Mov Disord; 2007 Aug; 22(11):1678-9. PubMed ID: 17534964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Iatrogenic gynecomastia in aldosterone-antagonist therapy].
    Quietzsch D
    Z Gesamte Inn Med; 1981 Feb; 36(3):87-9. PubMed ID: 7222857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced gynecomastia.
    Thompson DF; Carter JR
    Pharmacotherapy; 1993; 13(1):37-45. PubMed ID: 8094898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecomastia and impotence: complications of spironolactone therapy.
    Greenblatt DJ; Koch-Weser J
    JAMA; 1973 Jan; 223(1):82. PubMed ID: 4739107
    [No Abstract]   [Full Text] [Related]  

  • 10. [Old man with bosom].
    Winter M
    MMW Fortschr Med; 2006 Jun; 148(26):61. PubMed ID: 16875387
    [No Abstract]   [Full Text] [Related]  

  • 11. Unilateral gynecomastia and impotence during low-dose spironolactone administration in men.
    Zarren HS; Black PM
    Mil Med; 1975 Jun; 140(6):417-9. PubMed ID: 807887
    [No Abstract]   [Full Text] [Related]  

  • 12. Spironolactone-induced bilateral gynecomastia in a man detected by SPECT myocardial perfusion imaging.
    Farag AA; Andrikopoulou E; Hage FG
    J Nucl Cardiol; 2017 Apr; 24(2):742. PubMed ID: 27151301
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of spironolactone-induced gynecomastia.
    Rose LI; Underwood RH; Newmark SR; Kisch ES; Williams GH
    Ann Intern Med; 1977 Oct; 87(4):398-403. PubMed ID: 907238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance of spironolactone-induced gynecomastia with triamteren.
    Yamamoto S
    Intern Med; 2001 Jun; 40(6):550. PubMed ID: 11446686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complications of verospirone therapy].
    Bokarev IN; Baranova NV
    Klin Med (Mosk); 1987 Sep; 65(9):104-8. PubMed ID: 3695298
    [No Abstract]   [Full Text] [Related]  

  • 16. Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia.
    Fukuchi K; Sasaki H; Yokoya T; Noguchi T; Goto Y; Hayashida K; Ishida Y
    Clin Nucl Med; 2005 Feb; 30(2):105-6. PubMed ID: 15647677
    [No Abstract]   [Full Text] [Related]  

  • 17. Gynecomastia and antihypertensive therapy.
    Mosenkis A; Townsend RR
    J Clin Hypertens (Greenwich); 2004 Aug; 6(8):469-70. PubMed ID: 15308889
    [No Abstract]   [Full Text] [Related]  

  • 18. Male breast uptake in rubidium-82 PET due to spironolactone-induced gynecomastia.
    Kiehl EL; Shivapour DM; Goenka AH; Jaber WA
    J Nucl Cardiol; 2015 Oct; 22(5):1148-50. PubMed ID: 25537612
    [No Abstract]   [Full Text] [Related]  

  • 19. Gynaecomastia after spironolactone and potassium canrenoate.
    Bellati G; Idéo G
    Lancet; 1986 Mar; 1(8481):626. PubMed ID: 2869341
    [No Abstract]   [Full Text] [Related]  

  • 20. Spironolactone and endocrine dysfunction.
    Ann Intern Med; 1976 Nov; 85(5):630-6. PubMed ID: 984618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.